« Sudbury family hosts blood donor clinic in honour of family member ...Human Genome Sciences Announces Fourth Quarter and Full Year 2007 ... »

Proteolix Names Matthew Ferguson to Newly-Created Position of ...

02/26/08

Permalink 09:31:04 am, by Barry Email , 29 words   English (US)
Categories: myeloma

Proteolix Names Matthew Ferguson to Newly-Created Position of ...

Link: http://sev.prnewswire.com/health-care-hospitals/20080225/AQM08625022008-1.html

PR Newswire (press release), NY - 16 hours ago Carfilzomib is currently in Phase II clinical studies to evaluate its safety and efficacy in multiple myeloma, lymphoma and solid tumor malignancies.

July 2009
Mon Tue Wed Thu Fri Sat Sun
 << <   > >>
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Search

Categories

XML Feeds

multiple blogs